Answers are grounded in this paper and cite their sources.
Oral ulcers are a prevalent clinical condition with multifactorial etiologies, including trauma, infections, systemic diseases, and immune dysregulation. Sirtuins, particularly SIRT1, play an important role in regulating oxidative stress, inflammation, and cellular repair pathways. This rapid review, conducted using the PRISMA protocol, synthesizes current evidence on the role of sirtuins in oral ulcer pathophysiology and their potential as therapeutic targets. A comprehensive search identified 140 articles in PubMed, 41 in ScienceDirect, and 4 in the Cochrane Library, of which 1 study met the eligibility criteria. The findings indicate that SIRT1 expression in the oral ulcer rats model is significantly lower than in normal controls, whereas NF-κB and TNF-α levels are markedly elevated in the control group. Pharmacological activation of SIRT1 attenuates inflammation, highlighting its therapeutic potential. However, the limited sample sizes and the lack of clinical trials specifically addressing oral ulcers restrict the generalizability of these findings. Additional study is needed to validate these findings and investigate SIRT1-targeted treatments.
No takes yet. Share an insight, caveat, or question.
Kuswandani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: